Which of the following is a key benefit of the expanded newborn screening program?

Improved early diagnosis is a key benefit of the expanded newborn screening program because it allows for the timely detection of various metabolic and genetic disorders in newborns. This early identification is crucial because many of these conditions can lead to serious health complications, developmental delays, or even death if not addressed promptly. By screening newborns shortly after birth, healthcare providers have the opportunity to initiate early intervention strategies or treatments that can significantly improve outcomes and enhance the quality of life for affected infants.

The expanded newborn screening program typically includes a wider array of tests compared to standard practices, which means that even rare conditions can be detected before symptoms appear, further contributing to the overall health and well-being of the child. The emphasis on early diagnosis can also lead to better family support and planning for management of any identified conditions.

In terms of the other choices, while reduced healthcare costs might be an outcome of improved diagnosis and early interventions, it is not the primary focus of the expanded screening program. Increased laboratory workload is likely a consequence of the broader range of tests being performed, rather than a benefit. Standardized testing procedures can enhance reliability and consistency, but the main advantage that directly impacts patient care is the improved early diagnosis resulting from the expanded capabilities of newborn screening.